24 results
Safety and Effectiveness of SEP−363856 in Schizophrenia: Results of a 6-Month, Open-Label Extension Study
-
- Journal:
- CNS Spectrums / Volume 26 / Issue 2 / April 2021
- Published online by Cambridge University Press:
- 10 May 2021, pp. 148-149
-
- Article
-
- You have access
- Export citation
Lurasidone and risk for metabolic syndrome: results from short- and long-term clinical studies in patients with schizophrenia
-
- Journal:
- CNS Spectrums / Volume 26 / Issue 6 / December 2021
- Published online by Cambridge University Press:
- 14 September 2020, pp. 614-624
-
- Article
-
- You have access
- Open access
- HTML
- Export citation
Efficacy and safety of dasotraline in adults with binge-eating disorder: a randomized, placebo-controlled, fixed-dose clinical trial
-
- Journal:
- CNS Spectrums / Volume 26 / Issue 5 / October 2021
- Published online by Cambridge University Press:
- 19 May 2020, pp. 481-490
-
- Article
-
- You have access
- Open access
- HTML
- Export citation
138 Efficacy and Safety of SEP-363856, a Novel Psychotropic Agent with a Non-D2 Mechanism of Action, in the Treatment of Schizophrenia
-
- Journal:
- CNS Spectrums / Volume 25 / Issue 2 / April 2020
- Published online by Cambridge University Press:
- 24 April 2020, pp. 287-288
-
- Article
-
- You have access
- Export citation
170 Efficacy and Safety of Dasotraline in Adults with Binge-Eating Disorder: A Randomized, Double-blind, Fixed-dose Trial
-
- Journal:
- CNS Spectrums / Volume 25 / Issue 2 / April 2020
- Published online by Cambridge University Press:
- 24 April 2020, pp. 308-309
-
- Article
-
- You have access
- Export citation
180 Efficacy of Dasotraline in Children With Attention Deficit Hyperactivity Disorder in a Laboratory Classroom Setting
-
- Journal:
- CNS Spectrums / Volume 23 / Issue 1 / February 2018
- Published online by Cambridge University Press:
- 15 June 2018, p. 103
-
- Article
-
- You have access
- Export citation
113 Dasotraline for the Treatment of Moderate to Severe Binge Eating Disorder in Adults: Results From a Randomized, Double-Blind, Placebo-Controlled Study
-
- Journal:
- CNS Spectrums / Volume 23 / Issue 1 / February 2018
- Published online by Cambridge University Press:
- 15 June 2018, pp. 72-73
-
- Article
-
- You have access
- Export citation
108 Lurasidone in Children and Adolescents With Bipolar Depression Presenting With Mixed Features
-
- Journal:
- CNS Spectrums / Volume 23 / Issue 1 / February 2018
- Published online by Cambridge University Press:
- 15 June 2018, p. 70
-
- Article
-
- You have access
- Export citation
179 Dasotraline in Children With Attention Deficit Hyperactivity Disorder: Results of a Randomized, Double-Blind, Placebo-Controlled Study
-
- Journal:
- CNS Spectrums / Volume 23 / Issue 1 / February 2018
- Published online by Cambridge University Press:
- 15 June 2018, pp. 102-103
-
- Article
-
- You have access
- Export citation
109 Comparative Efficacy and Tolerability of Lurasidone Versus Other Oral Atypical Antipsychotics for Pediatric Schizophrenia: A Network Meta Analysis
-
- Journal:
- CNS Spectrums / Volume 23 / Issue 1 / February 2018
- Published online by Cambridge University Press:
- 15 June 2018, pp. 70-71
-
- Article
-
- You have access
- Export citation
Remission and recovery associated with lurasidone in the treatment of major depressive disorder with subthreshold hypomanic symptoms (mixed features): post-hoc analysis of a randomized, placebo-controlled study with longer-term extension—CORRIGENDUM
-
- Journal:
- CNS Spectrums / Volume 22 / Issue 4 / August 2017
- Published online by Cambridge University Press:
- 02 May 2017, p. 373
-
- Article
-
- You have access
- HTML
- Export citation
Lurasidone for major depressive disorder with mixed features and anxiety: a post-hoc analysis of a randomized, placebo-controlled study
-
- Journal:
- CNS Spectrums / Volume 22 / Issue 2 / April 2017
- Published online by Cambridge University Press:
- 30 March 2017, pp. 236-245
-
- Article
-
- You have access
- Open access
- HTML
- Export citation
Lurasidone for major depressive disorder with mixed features and irritability: a post-hoc analysis
-
- Journal:
- CNS Spectrums / Volume 22 / Issue 2 / April 2017
- Published online by Cambridge University Press:
- 16 March 2017, pp. 228-235
-
- Article
-
- You have access
- Open access
- HTML
- Export citation
Remission and recovery associated with lurasidone in the treatment of major depressive disorder with subthreshold hypomanic symptoms (mixed features): post-hoc analysis of a randomized, placebo-controlled study with longer-term extension
-
- Journal:
- CNS Spectrums / Volume 22 / Issue 2 / April 2017
- Published online by Cambridge University Press:
- 07 March 2017, pp. 220-227
-
- Article
-
- You have access
- Open access
- HTML
- Export citation
Long-term safety and effectiveness of lurasidone in schizophrenia: a 22-month, open-label extension study
-
- Journal:
- CNS Spectrums / Volume 21 / Issue 5 / October 2016
- Published online by Cambridge University Press:
- 06 April 2016, pp. 393-402
-
- Article
-
- You have access
- Open access
- HTML
- Export citation
Lurasidone: a novel antipsychotic agent for the treatment of schizophrenia and bipolar depression
-
- Journal:
- BJPsych Bulletin / Volume 39 / Issue 5 / October 2015
- Published online by Cambridge University Press:
- 02 January 2018, pp. 237-241
- Print publication:
- October 2015
-
- Article
-
- You have access
- Open access
- HTML
- Export citation
Ziprasidone in Black Patients with Schizophrenia: Analysis of Four Short-term, Double-blind Studies
-
- Journal:
- CNS Spectrums / Volume 14 / Issue 9 / September 2009
- Published online by Cambridge University Press:
- 07 November 2014, pp. 478-486
-
- Article
- Export citation
Improvement in Prosocial Functioning After a Switch to Ziprasidone Treatment
-
- Journal:
- CNS Spectrums / Volume 9 / Issue 5 / May 2004
- Published online by Cambridge University Press:
- 07 November 2014, pp. 357-363
-
- Article
- Export citation
Long-Term Improvement in Efficacy and Safety After Switching to Ziprasidone in Stable Outpatients with Schizophrenia
-
- Journal:
- CNS Spectrums / Volume 13 / Issue 10 / October 2008
- Published online by Cambridge University Press:
- 07 November 2014, pp. 898-905
-
- Article
- Export citation
Lurasidone for the treatment of depressive symptoms in schizophrenia: analysis of 4 pooled, 6-week, placebo-controlled studies
-
- Journal:
- CNS Spectrums / Volume 20 / Issue 2 / April 2015
- Published online by Cambridge University Press:
- 23 June 2014, pp. 140-147
-
- Article
-
- You have access
- Open access
- HTML
- Export citation